☆ 4.5 Editorial Material

Targeting constitutively active androgen receptor splice variants in castration resistant prostate cancer

EXPERT OPINION ON THERAPEUTIC TARGETS (2016)

Get Full Text
Add to Collection

Journal

EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 20, Issue 8, Pages 903-906

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.2016.1159676

Keywords

Androgen receptor; splice variants; prostate cancer; drug resistance

Categories

Pharmacology & Pharmacy

Funding

  1. NCI NIH HHS [P50 CA090381, P01 CA163227, P50 CA097186] Funding Source: Medline
  2. BLRD VA [I01 BX000585, I01 BX003324] Funding Source: Medline
  3. VA [5I01BX000585-03, 549385] Funding Source: Federal RePORTER

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.